MBX - Company ID 0001776111
MBX Biosciences, Inc. trades as MBX and has a market capitalization of $3.08 B, making it the #1801 largest US-listed company by market value. This page tracks MBX Biosciences, Inc. through 198 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Major company event | 8-K | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-08 |
| Insider sale notice | 144 | 2026-05-08 |
| Proxy materials | DEFA14A | 2026-05-08 |
| Insider trade | 4 | 2026-05-08 |
The largest companies sharing MBX Biosciences, Inc.'s SEC industry classification (pharmaceutical preparations).
MBX Biosciences, Inc. (MBX) has a market capitalization of $3.08 B as of 2026-07-09, ranking #1801 among US-listed companies.
In its latest fiscal year MBX Biosciences, Inc. reported a net loss of $87.00M.